A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome
Matsueda, Kei, Harasawa, Shigeru, Hongo, Michio, Hiwatashi, Nobuo, Sasaki, DaisukeVolume:
43
Language:
english
Journal:
Scandinavian Journal of Gastroenterology
DOI:
10.1080/00365520802240255
Date:
January, 2008
File:
PDF, 162 KB
english, 2008